GPC vs GSK · P/E 21, rev $12.80B vs P/E 13, $103.31B cap
Genuine Parts Co (GPC) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Genuine Parts Co (GPC) is a auto parts company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported GPC revenue for 2026-06-30 was $12.80B. Net income was $416.1M. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
GSK does not have a complete income-statement cache yet.
GPC currently screens at market cap $17.60B and trailing P/E 20.7. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the GPC and GSK stock pages for the full models.
Not investment advice.